These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7835626)

  • 1. Gastroprotective agents in mucosal defense against Helicobacter pylori.
    Slomiany BL; Murty VL; Piotrowski J; Slomiany A
    Gen Pharmacol; 1994 Sep; 25(5):833-41. PubMed ID: 7835626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.
    Slomiany BL; Piotrowski J; Slomiany A
    Arzneimittelforschung; 1997 Apr; 47(4A):475-82. PubMed ID: 9205747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulglycotide effect on the proteolytic and lipolytic activities of Helicobacter pylori toward gastric mucus.
    Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A; Slomiany BL
    Am J Gastroenterol; 1994 Feb; 89(2):232-6. PubMed ID: 8304309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide a virulence factor of Helicobacter pylori: effect of antiulcer agents.
    Piotrowski J
    J Physiol Pharmacol; 1998 Mar; 49(1):3-24. PubMed ID: 9594407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Helicobacter pylori glycosulfatase activity towards human gastric sulfomucin by a gastroprotective agent, sulglycotide.
    Murty VL; Piotrowski J; Czajkowski A; Slomiany A; Slomiany BL
    Gen Pharmacol; 1993 Nov; 24(6):1463-6. PubMed ID: 8112521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Helicobacter pylori colonization by an antiulcer agent, sulglycotide.
    Czajkowski A; Piotrowski J; Yotsumoto F; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1993 Apr; 29(5):965-71. PubMed ID: 8508147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of gastric somatostatin receptor inhibition by Helicobacter pylori lipopolysaccharide with ebrotidine and sulglycotide.
    Piotrowski J; Skrodzka D; Slomiany A; Slomiany BL
    Gen Pharmacol; 1997 May; 28(5):705-8. PubMed ID: 9184806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of Helicobacter pylori pathogenesis: focus on mucus.
    Slomiany BL; Slomiany A
    J Clin Gastroenterol; 1992; 14 Suppl 1():S114-21. PubMed ID: 1378466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosulfatase activity of H. pylori toward human gastric mucin: effect of sucralfate.
    Slomiany BL; Murty VL; Piotrowski J; Grabska M; Slomiany A
    Am J Gastroenterol; 1992 Sep; 87(9):1132-7. PubMed ID: 1381553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide: effect of sulglycotide.
    Piotrowski J; Majka J; Murty VL; Czajkowski A; Slomiany A; Slomiany BL
    Gen Pharmacol; 1994 Sep; 25(5):969-76. PubMed ID: 7835646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori lipopolysaccharide inhibition of gastric mucosal laminin receptor: effect of sulglycotide.
    Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A; Slomiany BL
    Gen Pharmacol; 1993 Nov; 24(6):1467-72. PubMed ID: 8112522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sucralfate counteracts the inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide.
    Slomiany A; Piotrowski J; Slomiany BL
    Scand J Gastroenterol Suppl; 1995; 210():77-81. PubMed ID: 8578214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sucralfate on the degradation of human gastric mucus by Helicobacter pylori protease and lipases.
    Slomiany BL; Piotrowski J; Slomiany A
    Am J Gastroenterol; 1992 May; 87(5):595-9. PubMed ID: 1595646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Helicobacter pylori glycosulfatase activity toward gastric sulfomucin by nitecapone.
    Murty VL; Piotrowski J; Morita M; Slomiany A; Slomiany BL
    Biochem Int; 1992 May; 26(6):1091-9. PubMed ID: 1632804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebrotidine effect on the proteolytic and lipolytic activities of Helicobacter pylori.
    Slomiany BL; Piotrowski J; Mojtahed H; Slomiany A
    Gen Pharmacol; 1992 Mar; 23(2):203-6. PubMed ID: 1639232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of gastric mucosal mucin receptor by H. pylori lipopolysaccharide: effect of ebrotidine.
    Slomiany BL; Piotrowski J; Murty VL; Slomiany A
    Gen Pharmacol; 1995 Nov; 26(7):1553-8. PubMed ID: 8690245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosulfatase activity of Helicobacter pylori towards gastric sulfomucin: effect of nitecapone.
    Slomiany BL; Murty VL; Piotrowski J; Morita M; Slomiany A
    J Physiol Pharmacol; 1993 Mar; 44(1):7-16. PubMed ID: 8518427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosulfatase activity of Helicobacter pylori toward gastric mucin.
    Slomiany BL; Murty VL; Piotrowski J; Liau YH; Sundaram P; Slomiany A
    Biochem Biophys Res Commun; 1992 Mar; 183(2):506-13. PubMed ID: 1372502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by sulglycotide.
    Slomiany BL; Piotrowski J; Slomiany A
    Gen Pharmacol; 1999 Feb; 32(2):251-7. PubMed ID: 10188628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omeprazole fails to suppress up-regulation of gastric mucosal endothelin-converting enzyme-1 by Helicobacter pylori lipopolysaccharide.
    Slomiany BL; Piotrowski J; Slomiany A
    J Physiol Pharmacol; 2000 Sep; 51(3):421-31. PubMed ID: 11016862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.